Tablette Médicale Pour Les Examens Cardiaques et le Diagnostic à distance.

CARDIO-PAD

Présenté par Mr. Arthur ZANG

Tablette Médicale Pour Les Examens Cardiaques et le Diagnostic à distance

Fondateur et Directeur General de Himore Medical S.A

®

>> GENESIS OF THE PROBLEMTHE HEART

Pumps blood toother organs

MAIN HUMAN BODY ORGAN

CARDIOVASCULAR DISEASES

(CVD)

INT

RO

DU

CT

ION

>> THE PROBLEM

Globally 17.3 MILLION DEATHS/YEAR

30% TOTAL MORTALITY

CARDIOVASCULAR DISEASES

INT

RO

DU

CT

ION

CENTRAL AFRICA

1.2 Million deaths/year 22% Total Mortality

>> BACKGROUNDCENTRAL AFRICA

INT

RO

DU

CT

ION

Less than 40 CARDIOLOGISTS for

More Than 20 MILLIONS PEOPLE

CAMEROON

>> THE SITUATIONFACTORS & CONSEQUENCES

Total Patient Cost

Transport

Exams Cost

Housing

+

+

I I SOLUTION:

REMOTE MEDICAL EXAMINATIONS • Reduce CVD mortality• Improve public health

INT

RO

DU

CT

ION

Perform ECG examinations in district hospitals modest budget, located in rural areas, no specialist cardiologist

Reduce risks and costs for patients Limited time and money

Facilitate the work of cardiologists Remote interpretation and computer-assisted diagnosis ,mobility in the workplace, better monitoring of patients

Management of biomedical data Large Scale, treatment, and remote access of data

OBJECTIVES

SO

LU

TIO

N

SOLUTION LOCAL LEVEL GLOBAL LEVEL

>> THE SOLUTIONTHE CARDIO-PAD

HospitalRecordingCardiac exams withthe Cardio-pad, Medical touch tablet

Perform ECG examinations for patients

Transmit exams to remote cardiologists

Intuitive user interface to help cardiologists make their diagnosis

Functionalities

Information storage and management of ECG exam notifications

Remote monitoring of patients

>> CARDIOGLOBARCHITECTURE

SO

LU

TIO

N

Overall Success: 97.7%

Test File Duration ofSignal

Total Number of Heartbeats

Heartbeats detected

False positives Heartbeats undetected

Percentage of success

100 60 secondes 74 74 0 0 100%

101 60 secondes 71 71 0 0 100%

102 60 secondes 73 72 0 1 98.63%

105 60 secondes 83 83 0 0 100%

210 60 secondes 93 97 4 0 95.69%

GEN

ESIS

Prof. Samuel KinguéCardiologist, medical science department of yaoundé

Prof. Claude TanghaPolytechnic high school Yaoundé

Prof. Pierre Tricot Polytechnic school france

Arthur ZangCreator of Cardio-Pad

CARDIOPAD TESTING RESULTS 2009-2010

GEN

ESIS

MASTER THESIS: CARDIOGLOBDESIGN AND DEVELOPMENT OF SYSTEM FOR

ACQUISITION, PROCESSING AND TRANSMISSION USING GSM OF CARDIAC

SIGNAL.

Prof. Samuel Kingué et Prof. Claude Tangha

17.5 / 20

CARDIOPAD TESTING RESULTS 2010-2011

GEN

ESE

MASTER DEGREE IN SOFWARE DESIGN ENGINEERING

TWO SCIENTIFIC PUBLICATIONS

AWARDS AND RECOGNITION

GEN

ESE

MICROSOFTSEMI-FINALISTS AT IMAGINE CUP COMPETITION

ORANGE TELECOM4th Place at African Social Entrepreneur competition

FING ORGANISATION Presented at “Carrefour des Possibles”

CARDIO-PADInnovation and competition

FEBRUARY 2011

NOVEMBER 2011

DECEMBER 2011

PadECGExam

3,6,12 Pistes

Fonctionnalités

FONCTIONNALITES DU CARDIOPAD20 juin 2012 au 30/11/2012

3.B

>> EXECUTION DU CHRONOGRAMME

PadECGScope ECGAnalyse

PADTRANSMIT

Transfert des données

Acquisition Processing Transmition X Storage Remote monitoring X Remote diagnostic X Mobility X Average Price $5 000 $2600

>>ADVANTAGES OF THE SOLUTION

SOLU

TION

CONVENTIONAL ECG DEVICES CARDIO-PAD

OURS CUSTOMERSBIG Hospitalscentral and general Hospitals

LABORATORIESPerforming examsregardless ofinterpretations

District HospitalsSmall rural hospital without cardiologist services

80 %

TARGET CUSTOMERS

STATUS OF THE PROJECTPrototype 2011

MANUFACTURINGFirst Tablet

MEDICAL DEVICES MANUFACTURING COMPANY

Himore Medical founded in 2012 in order to manufacture, commercialise

and bring to market the CARDIOGLOB solution.

COMPANY BACKGROUND

Grant Funded with $25,000 usd by the government of Cameroon

7 Employees

Private Investment of $5,000

Headquatered in Yaoundé, Cameroon associated with the

University of Yaoundé

One Issued Patent

Under Contract with Public Health Minister of Cameroon for

initial implementation of Cardioglob

THE TEAM

HIMORE MEDICAL : • 3 Software Engineers• 1 Biomedical Engineer• 2 Cardiologists• 1 Mathematician

STRATEGIC PARTNERS : Microsoft, Embest, Quickembedd

30 Finished Products from first Manufacturing round

FACEBOOKYOUTUBESOCIAL MEDIA MARKETING

>> CARDIOPAD IN THE NEWS

REVENUE MODEL2012-2013 2013-2014 2014-2015

Examination fee $20 $20 $20

x x x

Min. Exam/Machine

8 7 5

x x x

Total No. of Machine

30 60 100

x x x

No. working days 300 292 288

TOTAL. Annual $1,440,000 $2,452,000 $2,880,000

PROFIT DISTRIBUTION

2012-2013 2013-2014 2014-20150

500,000

1,000,000

1,500,000

2,000,000

2,500,000

3,000,000

3,500,000

$259,200 $441,360 $518,400

$720,000

$1,226,000$1,440,000$460,800

$784,640

$921,600

Cardiologist 18% Himore Medical 50%Hospital 32%

Capital need

• Himore Medical seeks $500,000 in additional investment to support further growth.

• Capital will be deployed as follows:• $300,000 to support manufacturing and

distribution of the Cardiopad• $200,000 to support development of future

products and generation of additional IP

Compelling investment highlights

• Strong Patent protection

• Attractive Market opportunity and unmet need

• Positive Social Impact

• Scalable Technology

• Innovative technology built on proven and secure platform that reduces the investment risks.

Contact• Site : facebook.com/cardiopad• Email : marc_arthur [email protected]• Tél : (+237) 94 42 61 25

LES MEMBRES DU PROJET• ING. Arthur ZANG• Prof. Samuel KINGUE• ING. JEAN CEDRIC EVINA ONDOA• ING. JEAN PIERRE ANGUISSA ABESSOLO

CARDIO-PAD IN HOSPITAL